Related Experiment Video
Updated: Sep 4, 2025
08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.2K
Elafin Reverses Intestinal Fibrosis by Inhibiting Cathepsin S-Mediated Protease-Activated Receptor 2
Ying Xie1, Lindsey Fontenot2, Andrea Chupina Estrada2
1Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California; Department of Gastroenterology, The First Hospital of China Medical University, Shenyang City, Liaoning Province, China.
Cellular and Molecular Gastroenterology and Hepatology
|July 15, 2022
Summary
Elafin effectively reverses intestinal fibrosis by inhibiting collagen synthesis through a novel mechanism involving cathepsin S. This finding suggests elafin as a potential therapeutic for Crohn's disease strictures.
Area of Science:
- Gastroenterology
- Molecular Biology
- Fibrosis Research
Background:
- Crohn's disease frequently leads to intestinal fibrosis and strictures, impacting patient health.
- Elafin, a protease inhibitor, is found at lower levels in fibrotic intestinal tissues of Crohn's disease patients.
Purpose of the Study:
- To investigate elafin's efficacy in reversing intestinal fibrosis.
- To elucidate the mechanism by which elafin acts against fibrosis.
Main Methods:
- Developed a model mimicking Crohn's disease fibrosis using patient-derived exosomes and fibroblasts.
- Utilized three distinct mouse models of intestinal fibrosis.
- Employed elafin formulations and gene overexpression techniques.
Main Results:
- Elafin reversed collagen synthesis in human tissues and fibroblasts.
- Identified cathepsin S as a key protease targeted by elafin, inhibiting downstream signaling pathways (PAR-2, ZEB1).
- Elafin administration reversed fibrosis in all tested mouse models, with oral formulation showing efficacy.
Conclusions:
- Elafin suppresses intestinal fibroblast collagen synthesis via cathepsin S-dependent inhibition of PAR-2 and reduced ZEB1 expression.
- This mechanism leads to the reversal of intestinal fibrosis.
- Modified elafin presents a promising therapeutic strategy for intestinal fibrosis.
